Avillion LLP and Merck KGaA have been shortlisted for the “Best Partnership Alliance” category for anti IL-17 A/F Nanobody in inflammatory diseases at the 13th Annual Scrip Awards.
The winners will be announced at the ceremony in London on the 29th November.
You can find all finalists for the awards here